Kathryn J. Potter - Concepedia

Author

Kathryn J. Potter

Also Known As

B Vakeesan, K J Potter, K Potter, K. J. Potter, K. POTTER, K. Potter, K.J. Potter, KATHRYN J. POTTER, Kathryn E Potter, Kathryn J Potter

Publications

1.5K

Citations

H-Index

Concepts

All Affiliations

University of British Columbia Child and Family Research Institute Montreal Clinical Research Institute Université de Montréal University of Alberta

About

Kathryn J. Potter is an author at University of British Columbia specializing in medicine, diabetes, and metabolic syndrome.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	10	11	708
2	Health Sciences	3	3	49
3	Natural Sciences	2	2	141
4	Education	1	1	25
5	Anesthesia	1	1	25

Kathryn J. Potter

Publications

1.1K

Citations

H-Index

Page 1

	Year	Citations
IL-1 Blockade Attenuates Islet Amyloid Polypeptide-Induced Proinflammatory Cytokine Release and Pancreatic Islet Graft Dysfunction Clara Westwell‐Roper, Derek L. Dai, Galina Soukhatcheva, The Journal of Immunology ImmunologyImmune RegulationImmunologic MechanismPancreas TransplantationImmunotherapy	2011	186
Islet amyloid deposition limits the viability of human islet grafts but not porcine islet grafts Kathryn J. Potter, Andisheh Abedini, Peter Marek, Proceedings of the National Academy of Sciences Porcine IappImmunologyTissue TransplantationPancreas TransplantationBiomedical Engineering	2010	169
Different Effects of FK506, Rapamycin, and Mycophenolate Mofetil on Glucose-Stimulated Insulin Release and Apoptosis in Human Islets James D. Johnson, Ziliang Ao, Peter Ao, Cell Transplantation	2009	153
Rifampicin Does Not Prevent Amyloid Fibril Formation by Human Islet Amyloid Polypeptide but Does Inhibit Fibril Thioflavin-T Interactions: Implications for Mechanistic Studies of β-Cell Death Fanling Meng, Peter Marek, Kathryn J. Potter, Biochemistry Mechanistic StudiesImmunologyCell DeathNeurochemical BiomarkersInflammation	2008	92
Evaluation of the ESPGHAN Celiac Guidelines in a North American Pediatric Population Dominica Gidrewicz, Kathryn J. Potter, Cynthia Trevenen, The American Journal of Gastroenterology	2015	83
Amyloid inhibitors enhance survival of cultured human islets Kathryn J. Potter, Louise A. Scrocchi, Garth L. Warnock, Biochimica et Biophysica Acta (BBA) - General Subjects Alzheimer's DiseaseMedicineDiabetesProtein MisfoldingPancreas Transplantation	2009	82
The Sulfated Triphenyl Methane Derivative Acid Fuchsin Is a Potent Inhibitor of Amyloid Formation by Human Islet Amyloid Polypeptide and Protects against the Toxic Effects of Amyloid Formation Fanling Meng, Andisheh Abedini, Annette Plesner, Journal of Molecular Biology Medicinal ChemistryBiochemistryPotent InhibitorNatural SciencesToxic Effects	2010	49
Prader–Willi-Like Phenotype Caused by an Atypical 15q11.2 Microdeletion Qiming Tan, Kathryn J. Potter, Lisa C. Burnett, Genes	2020	44
Mitochondria buffer NCX-mediated Ca2+-entry and limit its diffusion into vascular smooth muscle cells Damon Poburko, Kathryn J. Potter, Edo van Breemen, Cell Calcium Cell PhysiologyMolecular PhysiologyMitochondrial FunctionPhysiologyCytoskeleton	2006	36
Amyloid Formation in Human Islets Is Enhanced by Heparin and Inhibited by Heparinase Kathryn J. Potter, I. Werner, Heather C. Denroche, American Journal of Transplantation	2015	33

Page 1